
- •Air sampling and industrial hygiene engineering. Martha j. Boss & Dennis w. Day
- •4.1 Definitions
- •4.2 Example—outline of bulk sampling qa/qc procedure
- •4.3 Example—outline of the niosh 7400 qa procedure
- •4.3.1 Precision: Laboratory Uses a Precision of 0.45
- •4.3.2 Precision: Laboratory Uses a Precision sr that is Better Than 0.45
- •4.3.3 Records to Be Kept in a qa/qc System
- •4.3.4 Field Monitoring Procedures—Air Sample
- •4.3.5 Calibration
- •4.4 Sampling and analytical errors
- •95% Confident That the Employer Is in Compliance
- •95% Confident That the Employer Is not in Compliance
- •4.5 Sampling methods
- •4.5.1 Full-Period, Continuous Single Sampling
- •4.5.2 Full-Period, Consecutive Sampling
- •4.5.3 Grab Sampling
- •4.6 Calculations
- •4.6.1 Calculation Method for a Full-Period, Continuous Single Sample
- •4.6.2 Sample Calculation for a Full-Period, Continuous Single Sample
- •4.6.3 Calculation Method for a Full-Period Consecutive Sampling
- •4.7 Grab sampling
- •4.8 Saes—exposure to chemical mixtures
- •5.1 Baseline risk assessment
- •5.2 Conceptual site model
- •5.2.1 Source Areas
- •5.2.2 Possible Receptors
- •5.3 Chemicals of potential concern
- •5.4 Human health blra criteria
- •5.5 Toxicity assessment
- •5.6 Toxicological profiles
- •5.7 Uncertainties related to toxicity information
- •5.8 Potentially exposed populations
- •5.8.1 Exposure Pathways
- •5.8.2 Sources
- •5.9 Environmental fate and transport of copCs
- •5.10 Exposure points and exposure routes
- •5.11 Complete exposure pathways evaluated
- •5.12 Ecological risk assessment
- •5.13 Data evaluation and data gaps
- •5.14 Uncertainties
- •5.14.1 Uncertainties Related to Toxicity Information
- •5.14.2 Uncertainties in the Exposure Assessment
- •5.15 Risk characterization
- •5.16 Headspace monitoring—volatiles
- •5.18 Industrial monitoring—process safety management
- •5.19 Bulk samples
- •6.1 Fungi, molds, and risk
- •6.1.1 What Is the Difference between Molds, Fungi, and Yeasts?
- •6.1.2 How Would I Become Exposed to Fungi That Would Create a Health Effect?
- •6.1.3 What Types of Molds Are Commonly Found Indoors?
- •6.1.4 Are Mold Counts Helpful?
- •6.1.5 What Can Happen with Mold-Caused Health Disorders?
- •6.2 Biological agents and fungi types
- •6.2.1 Alternaria
- •6.3 Aspergillus
- •6.4 Penicillium
- •6.5 Fungi and disease
- •6.6 Fungi control
- •6.6.1 Ubiquitous Fungi
- •6.6.2 Infection
- •6.6.3 Immediate Worker Protection
- •6.6.4 Decontamination
- •6.6.5 Fungi and voCs
- •6.6.6 Controlling Fungi
- •6.7 Abatement
- •Indoor Air Quality and Environments
- •7.1 Ventilation design guide
- •7.2 Example design conditions guidance
- •7.2.1 Outside Design Conditions
- •7.2.2 Inside Design Conditions
- •7.3 Mechanical room layout requirements
- •7.4 Electrical equipment/panel coordination
- •7.5 General piping requirements
- •7.6 Roof-mounted equipment
- •7.7 Vibration isolation/equipment pads
- •7.8 Instrumentation
- •7.9 Redundancy
- •7.10 Exterior heat distribution system
- •7.10.1 Determination of Existing Heat Distribution Systems
- •7.10.2 Selection of Heat Distribution Systems
- •7.10.2.1 Ag Systems
- •7.10.2.2 Cst Systems
- •7.10.2.3 Buried Conduit (preapproved type)
- •7.10.2.4 Buried Conduit (not preapproved type)
- •7.11 Thermal insulation of mechanical systems
- •7.12 Plumbing system
- •7.12.1 Piping Run
- •7.13 Compressed air system
- •7.13.1 Compressor Selection and Analysis
- •7.13.2 Compressor Capacity
- •7.13.3 Compressor Location and Foundations
- •7.13.4 Makeup Air
- •7.13.5 Compressed Air Outlets
- •7.13.6 Refrigerated Dryer
- •7.14 Air supply and distribution system
- •7.14.1 Basic Design Principles
- •7.14.2 Temperature Settings
- •7.14.3 Air-Conditioning Loads
- •7.14.4 Infiltration
- •7.14.5 Outdoor Air Intakes
- •7.14.6 Filtration
- •7.14.7 Economizer Cycle
- •7.15 Ductwork design
- •7.15.3 Evaporative Cooling
- •7.16 Ventilation and exhaust systems
- •7.16.1 Supply and Exhaust Fans
- •7.17 Testing, adjusting, and balancing of hvac systems
- •7.18 Ventilation adequacy
- •7.19 Laboratory fume hood performance criteria
- •7.20 Flow hoods
- •7.21 Thermoanemometers
- •7.22 Other velometers
6.5 Fungi and disease
The main hazardous species belong to the following genera: Absidia, Alternaria, Aspergillus, Fusarium, Cladosporium, Cryptostroma, Mucor, Penicillium, and Stachybotrys. Various strains of these genera of molds have been implicated in being causative agents in asthma, hypersensitivity pneumonitis, and pulmonary mycosis. Fungi commonly found in ventilation systems and indoor environments include Absidia, Acremonium, Alternaria, Aspergillus, Aureobasidium, Botrytis, Cephalosporium, Chrysosporium, Cladosporium, Epicoc-cum, Fusarium, Helminthosporium, Mucor, Nigrospora, Penicillium, Phoma, Pithomyces, Rhinocladiella, Rhizopus, Scopulariopsis, Stachybotrys, Streptomyces, Stysanus, Ulocladium, Yeast, and Zygosporium.
6.5.1 Blastomyces dermatitidis
Local infections have occurred following accidental parenteral inoculation with infected tissues or cultures containing yeast forms of B. dermatitidis. Parenteral (subcutaneous) inoculation of these materials may cause local granulomas.
Pulmonary infections have occurred following the presumed inhalation of conidia; two individuals developed pneumonia and one had an osteolytic lesion from which B. dermatitidis was cultured. Presumably, pulmonary infections are associated only with sporu-lating mold forms (conidia).
6.5.2 Coccidioides immitis
Clinical disease may occur in 90% of an exposed indoor population. Infections acquired in nature are asymptomatic in 50% of these outdoor cases. Because of their size (2-5 ran), the arthroconidia are conducive to ready dispersal in air and retention in deep pulmonary spaces. The much larger size of the spherule (30-60 nm) considerably reduces the effectiveness of this form of the fungus as an airborne pathogen. Spherules of the fungus may be present in clinical specimens and animal tissues, and infectious arthroconidia may be present in mold cultures and soil samples. Inhalation of arthroconidia from soil samples, mold cultures, or following transformation from the spherule form in clinical materials is the primary hazard. Accidental percutaneous inoculation of the spherule form may result in local granuloma formation.
6.5.3 Histoplasma capsulation
Pulmonary infections have resulted from handling mold from cultures. Collecting and processing soil samples from endemic areas have caused pulmonary infections in laboratory workers. Encapsulated spores are resistant to drying and may remain viable for long periods. The small size of the infective conidia (less than 5 |xm) is conducive to airborne dispersal and intrapulmonary retention. The infective stage of this dimorphic fungus (conidia) is present in sporulating mold from cultures and in soil from endemic areas. The yeast form is in tissues or fluids from infected animals and may produce local infection following parenteral inoculation.
6.5.4 Sporothrix schenckii
Sporothrix schenckii has caused a substantial number of local skin or eye infections in laboratory personnel. Most cases have been associated with accidents and have involved splashing culture material into the eye, scratching or injecting infected material into the skin, or being bitten by an experimentally infected animal. Skin infections have also resulted from handling cultures or from the necropsy of animals. No pulmonary infections have been reported to result from laboratory exposure, although naturally occurring lung disease is thought to result from inhalation.
6.5.5 Pathogenic Members of the Genera Epidermophyton, Microsporum, and Trichophyton
Skin, hair, and nail infections by these dermatophytid molds are among the most prevalent of human infections. Agents are present in the skin, hair, and nails of human and animal hosts. Contact with infected animals with inapparent or apparent infections is the primary hazard. Cultures and clinical materials are not an important source of human infection.
6.5.6 Miscellaneous Molds
Several molds have caused serious infection in immunocompetent hosts following presumed inhalation or accidental subcutaneous inoculation from environmental sources. These agents are Cladosporium {Xylohypha) trichoides, Cladosporium bantianum, Penicillium marnefii, Exophiala (Wangiella) dermatitidis, Fonsecaea pedrosoi, and Dactylaria gallopava (Ochroconis gallopavum). The gravity of naturally acquired illness is sufficient to merit special precautions. Inhalation of conidia from sporulating mold cultures or accidental injection into the skin is a risk.
6.5.7 Fusarium
The corn fungus Fusarium moniliforme produces fusaric acid that behaves like a weak animal toxin, but combined with other mold toxins, it exaggerates the effects of the other toxins. Scientists consider that this may be the important role for fusaric acid. All isolates of the Fusarium-type molds produce this toxin, suggesting that this compound is probably more prevalent in the environment than was initially considered. These results indicate
that analyses and toxicity studies should also include this toxin along with other suspect toxins under field conditions. Fumonisins might be teratogenic to humans.